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The aortic wall is a complex structure, and ‘‘muchmore than
a tube.’’1 Ranging normally in dimension to as large as 3.2
cm in women and 3.6 cm in men,2 the aorta has a complex
physiologic function, which capitalizes on its normal elastic
properties to participate actively with the left ventricle in
a ‘‘game of catch’’ with the stroke volume.1 We will look
at 4 specific insights—new, emerging, and largely unpub-
lished—from 4 teams of theAortic Institute at Yale: clinical,
surgical pathology, engineering, and molecular genetics.
CLINICAL: CAN THE AORTIC WALL
COMMUNICATE WITH US?
It is well known that most patients with thoracic aortic
aneurysms (as many as 95%3) have no symptoms until dis-
section or rupture occurs. Some patients, however, indeed
do have symptoms, usually including chest pain. Wewished
to explore the significance of these symptoms. Specifically,
we looked at gross findings in the operating room in patients
with symptoms. Of 120 consecutive patients brought to the
operating room in a 22-month period for elective ascending
aortic replacement, 46 had symptoms. Although the inci-
dence of symptoms among our patients was greater than
expected, our patients had all sought care in some way
and were not culled from the general population, where
many asymptomatic aneurysms are to be found. For these
46 patients with symptoms, we reviewed the operative
and pathologic reports to look for findings that could be
expected to produce clinical pain. We looked specifically
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and focal wall necrosis or degeneration.
Such gross anatomic findings were indeed found fre-
quently among patients with symptoms. (Table 1 and
Figure 1). The frequency of abnormal gross anatomic find-
ings in patients with symptoms was, in fact, quite high. On
microscopy of the symptomatic aortas, inflammatory find-
ings abounded (details omitted in this overview). We be-
lieve that these findings ‘‘explain’’ the chest pain reported
by these patients. Many symptom-free patients also had
such anatomic findings, although at a much larger aortic
size and later stage of disease.
Because these gross anatomic findings indicate inflam-
mation (injection, adhesions) or focal wall deterioration
(thinning or bulging, intimal disruption, wall necrosis, or
degeneration), we consider them to be indicators of aortic
‘‘activity’’ that likely portend impending rupture or dissec-
tion. We therefore believe that these data lend support to the
long-standing surgical dictum that symptomatic aneurysms
merit resection regardless of size.
The anatomic neural pathways by which signals from the
distressed aortic wall can be relayed to higher brain centers
for processing have been elegantly described and illustrated
by Boudoulas and Stefanidis.4
SURGICAL PATHOLOGY: WHAT HAPPENS
ANATOMICALLY WHEN THE AORTIC WALL
THINS?
One often finds very impressive and frightening focal
wall thinning (‘‘bubbles’’) in patients undergoing elective
surgical resection (Figure 2). We have wondered what ana-
tomic changes underlie such ‘‘bubbles’’ in the aortic wall.
Accordingly, we have looked with our pathologists specifi-
cally at such areas under the light microscope.
What we have found is that the medial lamellae are lost in
such regions of extreme thinning or bubble formation. Elas-
tic fibers and smooth muscle cells are lost, giving way to
myxoid degeneration of the aortic wall. This process leaves
only intima and adventitia.
We believe that loss of the elastic media, which normally
buffers the force of aortic expansion in systole, reinforces
the obviously dangerous appearance of such lesions.
ENGINEERING: DO THE MECHANICS OF THE
AORTIC WALL CORRELATE WITH CLINICAL
BEHAVIOR?
Our group and others have studied the aorticwall via appli-
cation of engineering analytic principles.5 Most analyses ofgery c March 2013
TABLE 1. Frequency of positive gross anatomic findings among





Wall thinning or bulging 22 47
Intimal disruption 3 6
Wall necrosis or disruption 3 6
FIGURE 1. A, Note this localized disruption (arrow) of the ascending
aortic wall just above the aortic valve in a 38 year-old woman with persis-
tent chest pain despite imaging studies showing no evidence of dissection.
This disruption would likely have progressed to typical ascending aortic
dissection had surgery not been performed. B, Anatomic pathways by
which distress signals from the aortic wall can be relayed to higher centers
to produce pain. Signals travel along sensory nerves originating in the aor-
tic wall to the sympathetic chain and from there, through the rami commu-
nicantes, to the spinal cord, through which they ascend to the brain.
CNS, Central nervous system. Reprinted with permission from: Elefter-
iades JA. Controversies in diseases of the aorta: preface. Cardiol Clin.
2010;28:xvii. Boudoulas H, Stefanadis C. The aorta: structure, function,
dysfunction, and diseases. New York: Informa; 2009.
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pieces of the aortic wall. Of course, in real life the aortic
wall deforms in both longitudinal and in circumferential
directions.
One of us (S.W.) recently performed advanced engineer-
ing analysis of specimens of ascending aortic wall removed
at surgery. These specimens were processed immediately
on harvest to preserve full mechanical function. Further-
more, this investigator has tested our specimens in biaxial
deformation. This has permitted novel advanced engineer-
ing analysis and permitted expression of the behavior of
the aortic wall through exponential equations.
We have been astounded by the close correlation of
the engineering findings with the clinical behavior of the
aorta in patients (Figure 3). Inputting the precise ultimate
tensile strength from uniaxial testing into the equations
modeled from biaxial deformation permits exact ‘‘predic-
tion’’ of when dissection or rupture would have occurred
in a specific patient. Figure 3, A, shows that a particular
patient would have had dissection occur at a diameter of
5.29 cm and a pressure of 168 mm Hg. Rupture would
have occurred at a diameter of 5.47 cm and a pressure of
263 mm Hg. These parameters correlate well with our
recommendations, which are based on serial monitoring
of large cohorts of thoracic aortic aneurysm patients,
that prophylactic operation should be performed before a
diameter of 5.5 cm is attained.6 These parameters also cor-
relate nicely with our clinical findings that blood pressure
rises accompanying extreme exercise or emotion can in-
deed precipitate aortic dissection.7-9 These experiments
were done with incorporation of aortic size into the
equations but without consideration of body size or the
aortic size index, which we have used clinically to
‘‘adjust’’ for extremely small or large patients.10 We have
made initial comparisons of aortas from patients with
bicuspid aortic valves and those from patients with tricus-
pid aortic valves; no major differences in engineering prop-
erties have come to light.
This close correlation between engineering modeling
and clinical behavior of thoracic aortic aneurysms promises
to enhance our understanding of the pathophysiology of
acute aortic events and to refine our criteria for surgical
intervention.The Journal of Thoracic and Cardiovascular Surgery c Volume 145, Number 3S S131
FIGURE 2. A, Area of extreme thinning (‘‘bubble’’) in aortic wall. B, Histologic slide of area of severe thinning in aortic wall. Note degeneration of the
aortic media with loss of smooth muscle cells and elastic lamella, as well as myxoid degeneration in the center of the section. Normal aorta, not thinned and
with preserved media, is seen to the periphery of the section on the right and left.
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THE SURGICAL PATHOLOGY OF THE AORTIC
WALL?
To know the ongoing biology of the aortic wall would be
exceptionally helpful. The search for biomarkers of thoracic
aortic disease, although hopeful, has not yet yielded fruit.11
Markers of matrix metalloproteinases, of elastin and colla-
gen metabolism, of muscle proteins, and of cytokines have
not yet led to clinical fruition. Unfortunately, of course, the
aorta is not amenable to periodic biopsy.
Initial efforts are underway to usepositronemission tomog-
raphy to assess the aorticwall,with someearly limited success
in the abdominal region.12,13 The hope is that the finding of
increased metabolic uptake, signifying inflammation, can
validate a decision for prophylactic surgery.
With colleagues at Applied Biosystems (Life Technolo-
gies Corporation, Carlsbad, Calif), we recently published
results of an ‘‘RNA Signature’’ blood test that we hope
may ultimately come to represent a ‘‘virtual biopsy’’FIGURE 3. A, Engineering analysis combining ultimate tensile strength from
‘‘prediction’’ of exact sizes at which rupture and dissection would have occurr
the patient illustrated in panel A fall exactly in the size range for adverse event
from: Elefteriades JA, Rizzo JA. Epidemiology: incidence, prevalence, and trend
S132 The Journal of Thoracic and Cardiovascular Surindicative of ongoing molecular biology in the aortic
wall.14 Such monitoring of disease state by assessment of
RNA expression profiles in peripheral blood is being ap-
plied to various systemic diseases in addition to aneu-
rysms.14 It is becoming apparent that for these systemic
diseases, molecular activity in the blood reflects the under-
lying disease process.
If the DNA is the body’s blueprint, determining how the
‘‘house’’ will be built, then the RNA profiles reflect current
work activity in different ‘‘rooms’’ (eg, kitchen, den, ga-
rage). Some parts of the DNA are actively being transcribed
into specific RNA molecules for protein fabrication,
whereas others may be dormant.
We looked at RNA expressions in peripheral white blood
cells to assess the relative expression levels of more than
29,000 genes in patients with thoracic aortic aneurysm rel-
ative to healthy control subjects. Of those 29,000 genes,
some were upregulated compared to control levels, and
some were downregulated. We sifted out the 41 mostuniaxial testing with mathematic modeling from biaxial testing permits
ed (Video 1). B, Note that the predicted dissection and rupture points for
s (arrow) found in our previous clinical studies. Reprinted with permission
s. In: Elefteriades JA, editor.Acute aortic disease. NewYork: Informa; 2007.
gery c March 2013
FIGURE 4. A, Note the high sensitivity, specificity, and overall accuracy of the RNA Signature test in correctly discriminating between blood samples from
patients with thoracic aortic aneurysms and those from healthy control subjects. These values are certainly within or exceed the parameters of other clinical
screening tests in wide use. In the 3-dimensional plot on the right, if all the red patient dots and all the blue control dots were contained in their respective
3-dimensional ovals, the test would have been 100% accurate. B, Explanation of hierarchic cluster diagrams, now entering the literature in our specialty with
some frequency. C, If all the red dots representing aneurysm patients (TAA) and all the blue dots representing control subjects had been grouped together, the
test would have been 100% accurate; almost all the assignments were correct. Red represents overexpressed and green represents underexpressed. Reprinted
with permission fromWang Y, Barbacioru CC, Shiffman D, Balasubramanian S, Iakoubouva O, Tranquilli M, et al. Gene expression signature in peripheral
blood detects thoracic aortic aneurysm. PLoS One. 2007;2:e1050.
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measure this characteristic pattern of gene expression on
automated testing arrays, and we used the expression
pattern as a predictive test. Remarkably, sensitivity, speci-
ficity, and overall accuracy were about 80% in distinguish-
ing patients with thoracic aneurysms from healthy control
subjects. In essence, this novel RNA Signature appeared
to have significant potential as a general screening test for
thoracic aortic aneurysm. We published these results
a few years ago.14 A lethal, asymptomatic disease such as
thoracic aortic aneurysm cries out for a biomarker suitable
for screening of the general population. In Figure 4, one can
see visually displayed the considerable discriminative
power of the RNA Signature test.
We have not yet made the transition to clinical applica-
tion of this RNA Signature test, preferring rather to revali-
date our findings in a fresh cohort of patients before
proposing clinical use of this novel screening method. At
the time of the 2012 Aortic Symposium, we can reportThe Journal of Thoracic and Cardthat our first batch of replication samples confirms our
earlier findings; namely, that sensitivity, specificity, and
overall accuracy of the RNA Signature appear to be
satisfactory to justify clinical application. The remaining
batches of samples will be analyzed soon and, if confirma-
tory, will justify transitioning this research finding into
a clinical tool.
Most importantly, the metabolic pathways in which our
41 discriminatory genes reside subtend processes known
to be involved in the pathophysiology and genesis of tho-
racic aortic aneurysm—including inflammatory, apoptotic,
and proteolytic pathways. We are hopeful that, by sampling
peripheral blood, we may be able in the future to obtain
a virtual biopsy of molecular pathways in the aortic wall.
It is distinctly possible that specific alterations in expression
of key genes may precede and predict rupture and dissec-
tion. If this concept is borne out, such a virtual biopsy
may be able to augment and personalize our current ana-
tomic (size) criteria for surgical intervention.iovascular Surgery c Volume 145, Number 3S S133
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In summary, regarding these 4 questions about the aortic
wall, we may state the following:
1. Can the aorta communicate with us? Yes. Symptoms are
often accompanied by serious gross irregularities in the
appearance and structure of the aortic wall.
2. What happens anatomically when the aortic wall thins?
The elastic lamellar units of the media are lost, being re-
placed by myxoid material and leaving a vulnerable
aorta composed only of intima and adventitia.
3. Do the mechanics of the aortic wall correlate with clin-
ical behavior? Yes, emphatically so. Mathematic model-
ing derived from uniaxial and biaxial tensile testing
confirms that rupture and dissection can be expected in
the same size range, from 5 to 5.5 cm, as seen in our pre-
vious clinical studies.
4. Can we monitor the surgical pathology of the aortic
wall? The RNA Signature blood test promises to detect
aneurysms and possibly to permit a virtual biopsy of
molecular events reflective of the aortic wall.References
1. Elefteriades JA. Controversies in diseases of the aorta: preface. Cardiol Clin.
2010;28:xvii.
2. Vasan RS, Larson MG, Levy D. Determinants of echocardiographic root size: the
Framingham Heart Study. Circulation. 1995;91:734-40.S134 The Journal of Thoracic and Cardiovascular Sur3. Elefteriades JA, Rizzo JA. Epidemiology: incidence, prevalence, and trends. In:
Elefteriades JA, ed. Acute aortic disease. New York: Informa; 2007.
4. Boudoulas H, Stefanadis C. The aorta: structure, function, dysfunction, and dis-
eases. New York: Informa; 2009.
5. Koullias G, Modak R, Tranquilli M, Korkolis DP, Barash P, Elefteriades JA.
Mechanical deterioration underlies malignant behavior of human ascending
aorta. J Thoracic Cardiovasc Surg. 2005;130:677-83.
6. Coady MA, Rozzo JA, Hammond GL, Mandapati D, Darr U, Kopf GS,
et al. What is the appropriate size criterion for resection of thoracic
aortic aneurysms? J Thorac Cardiovasc Surg. 1997;113:476-89; discussion
489-91.
7. Elefteriades JA, Hatzaras I, Tranquilli MA, Elefteriades AJ, Stout R, Shaw RK,
et al.Weight lifting and rupture of silent aortic aneurysms. JAMA. 2003;290:2803.
8. Hatzaras I, Tranquilli M, Coady M, Barrett PM, Bible J, Elefteriades JA. Weight
lifting and aortic dissection: more evidence for a connection. Cardiology. 2007;
107:103-6.
9. Hatzaras IS, Bible JE, Koullias GG, Tranquilli M, SinghM, Elefteriades JA. Role
of exertion or emotion as inciting events for acute aortic dissection.Am J Cardiol.
2007;100:1470-2.
10. Davies RR, Gallo A, Coady MA, Tellides G, Botta DM, Burke B, et al. Novel
measurement of relative aortic size predicts rupture of thoracic aortic aneurysms.
Ann Thorac Surg. 2006;81:169-77.
11. Trimarchi S, Sangiorgi G, Sang X, Rampoldi V, Suzuki T, Eagle KA, et al. In
search of blood tests for thoracic aortic diseases. Ann Thorac Surg. 2010;90:
1735-42.
12. Truijers M, Kurvers HA, Bredie SJ, Oyen WJ, Blankensteijn JD. In vivo imaging
of abdominal aortic aneurysms: increased FDG uptake suggests inflammation in
the aneurysm wall. J Endovasc Ther. 2008;15:462-7.
13. Reeps C, Essler M, Pelisek J, Seidl S, Eckstein HH, Krause BJ. Increased
18F-fluorodeoxyglucose uptake in abdominal aortic aneurysms in positron emis-
sion/computed tomography is associated with inflammation, aortic wall instabil-
ity, and acute symptoms. J Vasc Surg. 2008;48:417-23; discussion 424.
14. Wang Y, Barbacioru CC, Shiffman D, Balasubramanian S, Iakoubouva O,
Tranquilli M, et al. Gene expression signature in peripheral blood detects thoracic
aortic aneurysm. PLoS One. 2007;2:e1050.gery c March 2013
